Molecular and cellular basis of the dose-rate-dependent adverse effects of radiation exposure in animal models. Part II: Hematopoietic system, lung and liver

J Radiat Res. 2023 Mar 23;64(2):228-249. doi: 10.1093/jrr/rrad003.

Abstract

While epidemiological data have greatly contributed to the estimation of the dose and dose-rate effectiveness factor (DDREF) for human populations, studies using animal models have made significant contributions to provide quantitative data with mechanistic insights. The current article aims at compiling the animal studies, specific to rodents, with reference to the dose-rate effects of cancer development. This review focuses specifically on the results that explain the biological mechanisms underlying dose-rate effects and their potential involvement in radiation-induced carcinogenic processes. Since the adverse outcome pathway (AOP) concept together with the key events holds promise for improving the estimation of radiation risk at low doses and low dose-rates, the review intends to scrutinize dose-rate dependency of the key events in animal models and to consider novel key events involved in the dose-rate effects, which enables identification of important underlying mechanisms for linking animal experimental and human epidemiological studies in a unified manner.

Keywords: animal; cancer; cell; epidemiology; low dose; low dose rate; radiation.

Publication types

  • Review

MeSH terms

  • Animals
  • Dose-Response Relationship, Radiation
  • Hematopoietic System*
  • Humans
  • Liver
  • Lung
  • Models, Animal
  • Neoplasms, Radiation-Induced*
  • Radiation Dosage
  • Radiation Exposure* / adverse effects
  • Risk Assessment / methods